J-Star Holding Co., Ltd (NASDAQ:YMAT) Short Interest Update

J-Star Holding Co., Ltd (NASDAQ:YMAT) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 65,449 shares, an increase of 237.5% from the August 31st total of 19,393 shares. Based on an average daily trading volume, of 3,670,029 shares, the days-to-cover ratio is presently 0.0 days. Approximately 2.0% of the company’s shares are short sold.

Analyst Ratings Changes

A number of research firms have issued reports on YMAT. Weiss Ratings cut J-Star from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 9th. Wall Street Zen upgraded shares of J-Star to a “hold” rating in a report on Saturday, June 27th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

J-Star Stock Up 9.1%

YMAT traded up $0.13 on Friday, hitting $1.56. The company’s stock had a trading volume of 914,253 shares, compared to its average volume of 3,803,338. J-Star has a 12 month low of $0.85 and a 12 month high of $13.00. The company’s 50 day simple moving average is $1.83 and its 200-day simple moving average is $2.38.

About J-Star

J-Star Holding Co, Ltd. is a pharmaceutical research and development services company that supports pharmaceutical and biotechnology businesses throughout the drug-development process. Through its operating subsidiaries, the company provides contract development services designed to help clients advance drug candidates from early development through clinical manufacturing.

J-Star’s services include preformulation studies, formulation development, analytical method development and validation, stability testing, and the production of clinical trial materials.